Similar articles

• Executive summary from the final reports of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS.

  [No authors listed] [No authors listed] Oncology (Williston Park). 1991 Apr;5(4):16, 18-9. Oncology (Williston Park). 1991. PMID: 1831034 No abstract available.
• AIDS, death, and the drug approval process.

  Berger JW. Berger JW. Am Pharm. 1991 Oct;NS31(10):45, 47. doi: 10.1016/s0160-3450(15)31327-1. Am Pharm. 1991. PMID: 1957799 No abstract available.
• Desperation drugs. Frustrated AIDs patients are spurring the FDA to relax the rules of the game.

  Begley S, Hager M, Wilson L. Begley S, et al. Newsweek. 1989 Aug 7;114(6):48-9, 51. Newsweek. 1989. PMID: 10293942 No abstract available.
• AIDS and the politics of drug lag.

  Vogel D. Vogel D. Public Interest. 1989 Summer;(96):73-85. Public Interest. 1989. PMID: 10294053 No abstract available.
• Drug-induced cardiac toxicity: emphasizing the role of electrocardiography in clinical research and drug development.

  Gussak I, Litwin J, Kleiman R, Grisanti S, Morganroth J. Gussak I, et al. J Electrocardiol. 2004 Jan;37(1):19-24. doi: 10.1016/j.jelectrocard.2003.11.003. J Electrocardiol. 2004. PMID: 15132365 Review.